Clincosm LogoSign in Get a demo

PERICOM: Multicentre Observational Study on Community Acquired Intraabdominal Infections Management

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Completed
CT.gov ID
NCT03544203
Collaborator
(none)
200
Enrollment
14
Locations
11.9
Actual Duration (Months)
14.3
Patients Per Site
1.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Intraabdominal infection require rapid care management including antibiotic therapy and source control. Morbidity and mortality associated with Intraabdominal infections remain high. French recommendations have been edited in 2000 further updated in 2014. Delay in diagnosis and surgery can lead to worsened outcomes. However, little data are available on early community-acquired intraabdominal infections management to identify risk factors of inadequate management.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Multicentre Observational Study on Community Acquired Intraabdominal Infections Management: the PERICOM Study
    Actual Study Start Date :
    Apr 1, 2018
    Actual Primary Completion Date :
    Feb 28, 2019
    Actual Study Completion Date :
    Mar 30, 2019

    Outcome Measures

    Primary Outcome Measures

    1. length of stay [6 month]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • ≥ 18 years

    • patients admitted to emergency department for a diagnosis of proven or suspected intraabdominal infection requiring surgery

    Exclusion Criteria:

    • primary intraabdominal infection

    • health-care associated intraabdominal infection

    • abdominal trauma

    • patient under guardianship

    • opt out consent

    • patient already enrolled in the present study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU d'Amiens Amiens France 80054
    2 CHU Angers Angers France 49033
    3 Hia Percy Clamart France
    4 CHU Clermont-Ferrand Clermont-Ferrand France 63000
    5 Hôpital Henri Mondor Créteil France 94010
    6 CHU Grenoble La Tronche Grenoble France 38700
    7 CHRU Lille Lille France 59037
    8 Lyon-Sud Pierre Bénite Lyon France
    9 AP HM La Timone Marseille France 13385
    10 Ap Hm La Timone Marseille France
    11 CHU Nimes Nîmes France 30029
    12 CHU Bichat Claude Bernard Paris France 75018
    13 Le Kremlin-Bicêtre Paris France 94270
    14 CHU Strasbourg Strasbourg France

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire de Nīmes

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Universitaire de Nīmes
    ClinicalTrials.gov Identifier:
    NCT03544203
    Other Study ID Numbers:
    • 2017-A03407-46
    First Posted:
    Jun 1, 2018
    Last Update Posted:
    May 3, 2019
    Last Verified:
    Jan 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Centre Hospitalier Universitaire de Nīmes
    intraabdominal infections
    peritonitis
    critically ill
    Additional relevant MeSH terms:
    Infections
    Communicable Diseases
    Intraabdominal Infections

    Study Results

    No Results Posted as of May 3, 2019